Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Philippe Collet

Showing results (151-160 of 376) with videos related to

Pageof 38
Sort By:
Archives of Cardiovascular Diseases|December 4, 2012
Impact of transfer time on mortality in acute coronary syndrome with ST-segment elevation treated by angioplastyJohanne Silvain, Jean-Baptiste Vignalou, Farzin Beygui, et al.
European Heart Journal. Acute Cardiovascular Care|July 31, 2014
Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segment elevation myocardial infarction. FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) 2010Etienne Puymirat, François Schiele, Pierre-Vladimir Ennezat, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 15, 2017
Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac proceduresPaul Guedeney, Nadjib Hammoudi, Guillaume Duthoit, et al.
European Journal of Preventive Cardiology|May 22, 2021
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysisBenoît Gerardin, Paul Guedeney, Anne Bellemain-Appaix, et al.
Thrombosis and Haemostasis|July 3, 2009
Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma levelVéronique Le Cam-Duchez, Claudine Soria, Claire Bal Dit Sollier, et al.
Thrombosis and Haemostasis|July 5, 2022
Resumption of Antiplatelet Therapy after Major BleedingTobias Geisler, Sven Poli, Kurt Huber, et al.
Journal of the American College of Cardiology|February 7, 2003
Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trialsJean Philippe Collet, Gilles Montalescot, Erika Fine, et al.
Archives of Cardiovascular Diseases|September 24, 2008
Feasibility of outpatient coronary angiography with "ad hoc" angioplastyArnaud Chaumeil, Farzin Beygui, Jean-Philippe Collet, et al.
Expert Review of Cardiovascular Therapy|March 31, 2012
Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelinesFrans Van de Werf, Diego Ardissino, Héctor Bueno, et al.
Circulation|September 4, 2008
Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) studyJean-Philippe Collet, Johanne Silvain, Antoine Landivier, et al.
Pageof 38

Showing results (151-160 of 376) with videos related to

Sort By:
Pageof 38
Archives of Cardiovascular Diseases|December 4, 2012
Impact of transfer time on mortality in acute coronary syndrome with ST-segment elevation treated by angioplastyJohanne Silvain, Jean-Baptiste Vignalou, Farzin Beygui, et al.
European Heart Journal. Acute Cardiovascular Care|July 31, 2014
Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segment elevation myocardial infarction. FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) 2010Etienne Puymirat, François Schiele, Pierre-Vladimir Ennezat, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 15, 2017
Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac proceduresPaul Guedeney, Nadjib Hammoudi, Guillaume Duthoit, et al.
European Journal of Preventive Cardiology|May 22, 2021
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysisBenoît Gerardin, Paul Guedeney, Anne Bellemain-Appaix, et al.
Thrombosis and Haemostasis|July 3, 2009
Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma levelVéronique Le Cam-Duchez, Claudine Soria, Claire Bal Dit Sollier, et al.
Thrombosis and Haemostasis|July 5, 2022
Resumption of Antiplatelet Therapy after Major BleedingTobias Geisler, Sven Poli, Kurt Huber, et al.
Journal of the American College of Cardiology|February 7, 2003
Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trialsJean Philippe Collet, Gilles Montalescot, Erika Fine, et al.
Archives of Cardiovascular Diseases|September 24, 2008
Feasibility of outpatient coronary angiography with "ad hoc" angioplastyArnaud Chaumeil, Farzin Beygui, Jean-Philippe Collet, et al.
Expert Review of Cardiovascular Therapy|March 31, 2012
Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelinesFrans Van de Werf, Diego Ardissino, Héctor Bueno, et al.
Circulation|September 4, 2008
Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) studyJean-Philippe Collet, Johanne Silvain, Antoine Landivier, et al.
Pageof 38